(Q35964705)

11 August 2017

1 reference

title

Agents in development for prostate cancer prevention. (English)

1 reference

11 August 2017

1 reference

William G Nelson

1

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

Expert Opinion on Investigational Drugs

11 August 2017

published in

1 reference

11 August 2017

volume

13

1 reference

11 August 2017

issue

12

1 reference

11 August 2017

page(s)

1541-1554

1 reference

International trends and patterns of prostate cancer incidence and mortality

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Mendelian inheritance of familial prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Genome‐wide scan for prostate cancer susceptibility genes in the Johns Hopkins hereditary prostate cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Germline mutations in the ribonuclease L gene in families showing linkage with HPC1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Common sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Interferon-induced synthesis of 2-5A-dependent RNase in mouse JLS-V9R cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Expression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator of interferon action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Is the class A macrophage scavenger receptor (SR-A) multifunctional? - The mouse's tale

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Macrophage class A scavenger receptor-mediated phagocytosis of Escherichia coli: role of cell heterogeneity, microbial strain, and culture conditions in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Protection from lethal gram-positive infection by macrophage scavenger receptor-dependent phagocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Prostatitis: what is the role of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Epidemiologic association between prostatitis and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Ki-67 expression in early prostate cancer and associated pathological lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

GSTA1 expression in normal, preneoplastic, and neoplastic human prostate tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Hypermethylation of CpG islands in primary and metastatic human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Molecular Cloning of Human and Rat Complementary DNA Encoding Androgen Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Prostate-specific antigen expression is regulated by an upstream enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

The development of androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Hormonal, cellular, and molecular control of prostatic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Activation of the human androgen receptor through a protein kinase A signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Molecular determinants of resistance to antiandrogen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Steroid 5 alpha-reductase: two genes/two enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Characterization of 5alpha-reductase gene expression in stroma and epithelium of human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Decreased gene expression of steroid 5 alpha-reductase 2 in human prostate cancer: implications for finasteride therapy of prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Mechanism of Time-Dependent Inhibition of 5.alpha.-Reductases by .DELTA.1-4-Azasteroids: Toward Perfection of Rates of Time-Dependent Inhibition by Using Ligand-Binding Energies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

The influence of finasteride on the development of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Does finasteride alter the pathology of the prostate and cancer grading?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Radical causes of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Effect of antioxidants on androgen-induced AP-1 and NF-kappaB DNA-binding activity in prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Manganese superoxide dismutase (MnSOD) polymorphism, alpha-tocopherol supplementation and prostate cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study (Finland).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

A prospective study of plasma selenium levels and prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Mechanism and regulation of selenoprotein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Vegetables, fruits, associated micronutrients, and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Intake of carotenoids and retinol in relation to risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

A prospective study of tomato products, lycopene, and prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Persuasive evidence that quinone reductase type 1 (DT diaphorase) protects cells against the toxicity of electrophiles and reactive forms of oxygen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

The design of a randomized, placebo-controlled trial of celecoxib in preprostatectomy men with clinically localized adenocarcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Prostate cancer prevention agent development: Criteria and pipeline for candidate chemoprevention agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Chemotherapeutic prevention studies of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Comparative efficiency of prostate-specific antigen screening strategies for prostate cancer detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Use of proteomic patterns in serum to identify ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Prevalence of a Physician-Assigned Diagnosis of Prostatitis: The Olmsted County Study of Urinary Symptoms and Health Status Among Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Extended field prostate biopsies: too much of a good thing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

Inhibition of cell-free protein synthesis by pppA2′ p5′ A2′ p5′ A: a novel oligonucleotide synthesized by interferon-treated L cell extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.12.1541

10.1517/13543784.13.12.1541

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference